Butorphanol Tartrate Injection, Solution
Product Images NDC 0409-1623

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Butorphanol Tartrate (NDC 0409-1623). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Butorphanol 01)

Chemical structure diagram showing the molecular formulas of butorphanol and tartaric acid. The left structure represents the bicyclic ring and functional groups of butorphanol, and the right structure depicts the tartaric acid molecule.*

FDA Label Image

Figure 1 (Butorphanol 02)

A pharmacokinetic line graph showing plasma concentration (ng/mL) of butorphanol tartrate over time (hours) for intravenous (IV) and intramuscular (IM) administration. The graph uses a logarithmic scale for concentration, with IV data represented by circles and IM by triangles, illustrating the decline in plasma levels up to 12 hours post-dose.*

FDA Label Image

Hospira Logo (Butorphanol 03)

FDA Label Image

Principal Display Panel (2 mg/mL Vial Label)

BUTORPHANOL TARTRATE Injection, USP 2 mg/mL single-dose vial label. The label indicates a 1 mL vial for intramuscular or intravenous use. Distributed by Hospira, Inc., Lake Forest, IL. Storage instructions and part of the National Drug Code (NDC) are visible.*

FDA Label Image

Principal Display Panel (2 mg/mL Vial Carton)

Packaging label for Butorphanol Tartrate injection, USP, 2 mg/mL in 1 mL single-dose fliptop vials. The carton contains 10 vials and is distributed by Hospira, Inc. The label includes storage instructions, aseptic technique guidance, and ingredient information. The product is Rx only and made in Great Britain.*

FDA Label Image

Principal Display Panel (4 mg/2 mL Vial Label)

Label for Butorphanol Tartrate Injection USP 4 mg/2 mL (2 mg/mL) single-dose vial. The label indicates it is a prescription medication for intramuscular or intravenous use, distributed by Hospira, Inc., Lake Forest, IL, USA. Storage instructions specify 20 to 25°C (68 to 77°F).*

FDA Label Image

Principal Display Panel (4 mg/2 mL Vial Carton)

Packaging label for BUTORPHANOL TARTRATE Injection USP, 4 mg/2 mL (2 mg/mL), distributed by Hospira, Inc. The label indicates single-dose fliptop vials, 2 mL volume, with a pack containing 10 vials. Usage instructions specify intramuscular or intravenous administration. The label includes storage instructions, ingredients per mL, and a barcode. The product is made in Great Britain.*

FDA Label Image

Principal Display Panel (1 mg/mL Vial Label)

Label for Butorphanol Tartrate Injection, USP 1 mg/mL single-dose vial for intramuscular or intravenous use. The label indicates it is Rx only and distributed by Hospira, Inc., Lake Forest, IL. Storage instructions specify 20 to 25°C (68 to 77°F).*

FDA Label Image

Principal Display Panel (1 mg/mL Vial Carton)

Packaging label for Butorphanol Tartrate Injection, USP 1 mg/mL in 1 mL single-dose fliptop vials, 10 vials per carton. Distributed by Hospira, Inc. Label includes NDC 0409-1623-01, directions for intramuscular or intravenous use, storage instructions, and ingredient information. The label is primarily white with red and black text and features the Hospira logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.